MARATTO

retraction · Pharmaceuticals

RETRACTED: Ibrahim et al. Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity. Pharmaceuticals 2020, 13, 393

2026Open accessZagazig University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The journal retracts the article titled, "Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity" [...].

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3390/ph19081174

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.